Importer of Controlled Substances Application: Alcami Carolinas Corporation

Published date08 July 2021
Citation86 FR 36160
Record Number2021-14533
SectionNotices
CourtDrug Enforcement Administration
Federal Register, Volume 86 Issue 128 (Thursday, July 8, 2021)
[Federal Register Volume 86, Number 128 (Thursday, July 8, 2021)]
                [Notices]
                [Page 36160]
                From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
                [FR Doc No: 2021-14533]
                [[Page 36160]]
                =======================================================================
                -----------------------------------------------------------------------
                DEPARTMENT OF JUSTICE
                Drug Enforcement Administration
                [Docket No. DEA-863]
                Importer of Controlled Substances Application: Alcami Carolinas
                Corporation
                AGENCY: Drug Enforcement Administration, Justice.
                ACTION: Notice of application.
                -----------------------------------------------------------------------
                SUMMARY: Alcami Carolinas Corporation has applied to be registered as
                an importer of basic class(es) of controlled substance(s). Refer to
                Supplemental Information listed below for further drug information.
                DATES: Registered bulk manufacturers of the affected basic class(es),
                and applicants therefore, may file written comments on or objections to
                the issuance of the proposed registration on or before August 9, 2021.
                Such persons may also file a written request for a hearing on the
                application on or before August 9, 2021.
                ADDRESSES: Written comments should be sent to: Drug Enforcement
                Administration, Attention: DEA Federal Register Representative/DPW,
                8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a
                hearing must be sent to: Drug Enforcement Administration, Attn:
                Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All
                requests for a hearing should also be sent to: (1) Drug Enforcement
                Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive,
                Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
                Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive,
                Springfield, Virginia 22152.
                SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this
                is notice that on May 18, 2021, Alcami Carolinas Corporation, 1726
                North 23rd Street, Wilmington, North Carolina 28405-1822, applied to be
                registered as an importer of the following basic class(es) of
                controlled substance(s):
                ------------------------------------------------------------------------
                 Drug
                 Controlled substance code Schedule
                ------------------------------------------------------------------------
                Psilocybin............................. 7437 I
                Psilocyn............................... 7438 I
                Pentobarbital.......................... 2270 II
                Thebaine............................... 9333 II
                ------------------------------------------------------------------------
                 The company plans to import the listed controlled substances in
                bulk for the manufacturing of capsules/tablets for Phase II clinical
                trials. The company plans to import derivatives of Thebaine that have
                been determined by DEA to be captured under drug code (9333) Thebaine.
                No other activity for these drug code is authorized for this
                registration.
                 Approval of permit applications will occur only when the
                registrant's business activity is consistent with what is authorized
                under 21 U.S.C. 952(a)(2). Authorization will not extend to the import
                of Food and Drug Administration-approved or non-approved finished
                dosage forms for commercial sale.
                William T. McDermott,
                Assistant Administrator.
                [FR Doc. 2021-14533 Filed 7-7-21; 8:45 am]
                BILLING CODE P
                

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT